{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE327nnn/GSE327189/"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":[" Other","Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE327189"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: immunogenicity and efficacy from a randomized Phase I trial","description":"TG4050 is a personalized vaccine targeting point mutations of the tumors.. This study allows the characterization of transcriptome and vdj rearrangements of tumor antigen specific CD8+ T cells elicited by personalized vaccines.","dates":{"publication":"2026/06/23"},"accession":"GSE327189","cross_references":{"GSM":["GSM9651078","GSM9651077","GSM9651079","GSM9651081","GSM9651080"],"GPL":["15520"],"GSE":["327189"],"taxon":["Homo sapiens"]}}